These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
235 related items for PubMed ID: 17376894
1. Host transcription profiles upon primary respiratory syncytial virus infection. Janssen R, Pennings J, Hodemaekers H, Buisman A, van Oosten M, de Rond L, Oztürk K, Dormans J, Kimman T, Hoebee B. J Virol; 2007 Jun; 81(11):5958-67. PubMed ID: 17376894 [Abstract] [Full Text] [Related]
2. MIP-1alpha is produced but it does not control pulmonary inflammation in response to respiratory syncytial virus infection in mice. Domachowske JB, Bonville CA, Gao JL, Murphy PM, Easton AJ, Rosenberg HF. Cell Immunol; 2000 Nov 25; 206(1):1-6. PubMed ID: 11161432 [Abstract] [Full Text] [Related]
3. Respiratory syncytial virus persistence: evidence in the mouse model. Mejías A, Chávez-Bueno S, Gómez AM, Somers C, Estripeaut D, Torres JP, Jafri HS, Ramilo O. Pediatr Infect Dis J; 2008 Oct 25; 27(10 Suppl):S60-2. PubMed ID: 18820580 [Abstract] [Full Text] [Related]
4. An immunocompromised BALB/c mouse model for respiratory syncytial virus infection. Kong X, Hellermann GR, Patton G, Kumar M, Behera A, Randall TS, Zhang J, Lockey RF, Mohapatra SS. Virol J; 2005 Feb 08; 2():3. PubMed ID: 15701174 [Abstract] [Full Text] [Related]
5. Upregulation of TLR7 and TLR3 gene expression in the lung of respiratory syncytial virus infected mice. Huang S, Wei W, Yun Y. Wei Sheng Wu Xue Bao; 2009 Feb 08; 49(2):239-45. PubMed ID: 19445181 [Abstract] [Full Text] [Related]
6. Effect of respiratory syncytial virus on the activity of matrix metalloproteinase in mice. Li W, Shen HH. Chin Med J (Engl); 2007 Jan 05; 120(1):5-11. PubMed ID: 17254480 [Abstract] [Full Text] [Related]
7. Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways. Haeberle HA, Takizawa R, Casola A, Brasier AR, Dieterich HJ, Van Rooijen N, Gatalica Z, Garofalo RP. J Infect Dis; 2002 Nov 01; 186(9):1199-206. PubMed ID: 12402188 [Abstract] [Full Text] [Related]
9. Respiratory syncytial virus protects against the subsequent development of Japanese cedar pollen-induced allergic responses. Liu B, Kimura Y. J Med Virol; 2007 Oct 01; 79(10):1600-5. PubMed ID: 17705182 [Abstract] [Full Text] [Related]
10. ERK-1/2 activity is required for efficient RSV infection. Kong X, San Juan H, Behera A, Peeples ME, Wu J, Lockey RF, Mohapatra SS. FEBS Lett; 2004 Feb 13; 559(1-3):33-8. PubMed ID: 14960303 [Abstract] [Full Text] [Related]
11. Induction of mucosal B-cell memory by intranasal immunization of mice with respiratory syncytial virus. Valosky J, Hishiki H, Zaoutis TE, Coffin SE. Clin Diagn Lab Immunol; 2005 Jan 13; 12(1):171-9. PubMed ID: 15643003 [Abstract] [Full Text] [Related]
12. RNA interference inhibits respiratory syncytial virus replication and disease pathogenesis without inhibiting priming of the memory immune response. Zhang W, Tripp RA. J Virol; 2008 Dec 13; 82(24):12221-31. PubMed ID: 18818323 [Abstract] [Full Text] [Related]
13. DSCG reduces RSV-induced illness in RSV-infected mice. Hashimoto K, Mori S, Hashimoto Y, Kaneko H, Ishibashi K, Ishioka K, Kawasaki Y, Peebles RS, Munakata M, Hosoya M, Suzutani T. J Med Virol; 2009 Feb 13; 81(2):354-61. PubMed ID: 19107959 [Abstract] [Full Text] [Related]
15. Primary infection of mice with high titer inoculum respiratory syncytial virus: characterization and response to antiviral therapy. Bolger G, Lapeyre N, Dansereau N, Lagacé L, Berry G, Klosowski K, Mewhort T, Liuzzi M. Can J Physiol Pharmacol; 2005 Feb 13; 83(2):198-213. PubMed ID: 15791294 [Abstract] [Full Text] [Related]
16. Effects of repeated respiratory syncytial virus infections on pulmonary dendritic cells in a murine model of allergic asthma. Hirose H, Matsuse H, Fukahori S, Tsuchida T, Tomari S, Kawano T, Fukushima C, Mizuta Y, Kohno S. Int Arch Allergy Immunol; 2008 Feb 13; 147(3):197-205. PubMed ID: 18594149 [Abstract] [Full Text] [Related]
17. Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum. Graham BS, Davis TH, Tang YW, Gruber WC. Pediatr Res; 1993 Aug 13; 34(2):167-72. PubMed ID: 8233720 [Abstract] [Full Text] [Related]
18. Age-related differences in pulmonary cytokine response to respiratory syncytial virus infection: modulation by anti-inflammatory and antiviral treatment. Boukhvalova MS, Yim KC, Kuhn KH, Hemming JP, Prince GA, Porter DD, Blanco JC. J Infect Dis; 2007 Feb 15; 195(4):511-8. PubMed ID: 17230410 [Abstract] [Full Text] [Related]
19. A recombinant vaccinia virus encoding the interferon-inducible T-cell alpha chemoattractant is attenuated in vivo. Hamilton NH, Mahalingam S, Banyer JL, Ramshaw IA, Thomson SA. Scand J Immunol; 2004 Mar 15; 59(3):246-54. PubMed ID: 15030574 [Abstract] [Full Text] [Related]
20. Intranasal immunization with a replication-deficient adenoviral vector expressing the fusion glycoprotein of respiratory syncytial virus elicits protective immunity in BALB/c mice. Fu Y, He J, Zheng X, Wu Q, Zhang M, Wang X, Wang Y, Xie C, Tang Q, Wei W, Wang M, Song J, Qu J, Zhang Y, Wang X, Hong T. Biochem Biophys Res Commun; 2009 Apr 17; 381(4):528-32. PubMed ID: 19233131 [Abstract] [Full Text] [Related] Page: [Next] [New Search]